Laboratory of General Physiology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, 27100 Pavia, Italy.
Research Centre, Salahaddin University-Erbil, 44001 Erbil, Iraq.
Int J Mol Sci. 2019 Aug 14;20(16):3962. doi: 10.3390/ijms20163962.
It has long been known that endothelial Ca signals drive angiogenesis by recruiting multiple Ca-sensitive decoders in response to pro-angiogenic cues, such as vascular endothelial growth factor, basic fibroblast growth factor, stromal derived factor-1α and angiopoietins. Recently, it was shown that intracellular Ca signaling also drives vasculogenesis by stimulation proliferation, tube formation and neovessel formation in endothelial progenitor cells. Herein, we survey how growth factors, chemokines and angiogenic modulators use endothelial Ca signaling to regulate angiogenesis and vasculogenesis. The endothelial Ca response to pro-angiogenic cues may adopt different waveforms, ranging from Ca transients or biphasic Ca signals to repetitive Ca oscillations, and is mainly driven by endogenous Ca release through inositol-1,4,5-trisphosphate receptors and by store-operated Ca entry through Orai1 channels. Lysosomal Ca release through nicotinic acid adenine dinucleotide phosphate-gated two-pore channels is, however, emerging as a crucial pro-angiogenic pathway, which sustains intracellular Ca mobilization. Understanding how endothelial Ca signaling regulates angiogenesis and vasculogenesis could shed light on alternative strategies to induce therapeutic angiogenesis or interfere with the aberrant vascularization featuring cancer and intraocular disorders.
长期以来,人们一直知道内皮细胞 Ca 信号通过响应促血管生成信号(如血管内皮生长因子、碱性成纤维细胞生长因子、基质衍生因子-1α 和血管生成素)招募多个 Ca 敏感解码器来驱动血管生成。最近,有人指出,细胞内 Ca 信号也通过刺激内皮祖细胞的增殖、管形成和新血管形成来驱动血管发生。在此,我们调查了生长因子、趋化因子和血管生成调节剂如何利用内皮细胞 Ca 信号来调节血管生成和血管发生。内皮细胞对促血管生成信号的 Ca 反应可能采用不同的波形,从 Ca 瞬变或双相 Ca 信号到重复的 Ca 振荡不等,主要通过内源性 Ca 释放通过肌醇 1,4,5-三磷酸受体和通过 Orai1 通道的储存操作 Ca 进入来驱动。然而,通过烟酰胺腺嘌呤二核苷酸磷酸门控双孔通道的溶酶体 Ca 释放正在成为一个关键的促血管生成途径,它维持细胞内 Ca 动员。了解内皮细胞 Ca 信号如何调节血管生成和血管发生,可以为诱导治疗性血管生成或干扰癌症和眼内疾病特征的异常血管化提供替代策略。